Pigmented Villonodular Synovitis - 9 Studies Found
Completed |
: Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) : Pigmented Villonodular Synovitis : 2010-12-15 : Drug: Tasigna The study drug is nilotinib (Tasigna®). |
Recruiting |
: Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor :
|
Active, not recruiting |
: PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) :
|
Active, not recruiting |
: Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor :
|
Recruiting |
: MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCTTS) :
|
Recruiting |
: A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor :
|
RECRUITING |
: A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT : Pigmented Villonodular Synovitis : 2024-05-13 : A fully human monoclonal immunoglobulin (IgG2) directed against c-fms |